Monday, August 07, 2017 10:34:10 AM
strong institutional support here:
MBRX:
Institutional holders:
Moleculin Biotech Inc, Inst Holders, 2Q 2017 (MBRX)
4:15 am ET July 20, 2017 (Dow Jones) Print
The following table shows the largest shareholders in MOLECULIN BIOTECH INC COM (MBRX) for the quarter ended June 30, 2017, listed by holding size. The list represents up to 50 of the largest holders in the company.
Institution Shares Shares % Last
Held Changed Held Report
The Vanguard Group Inc. 264,160 246,202 1.488 03/31
KCG Americas LLC 233,994 233,994 1.318 03/31
Sabby Capital LLC 100,000 100,000 0.563 03/31
Sterling Capital Management LL 40,000 20,000 0.225 03/31
Bank of America NA (Private B 25,000 0 0.141 03/31
Two Sigma Securities LLC 24,160 24,160 0.136 03/31
BlackRock Fund Advisors 17,868 0 0.101 03/31
Goldman Sachs & Co. LLC (Priva 17,509 17,509 0.099 03/31
Citadel Advisors LLC 17,304 17,304 0.097 03/31
Northern Trust Investments In 11,155 11,155 0.063 03/31
Morgan Stanley & Co. LLC 10,096 10,096 0.057 03/31
Wedbush Securities Inc. (Inve 10,000 10,000 0.056 03/31
UBS Securities LLC 4,537 2,415 0.026 03/31
Tower Research Capital LLC 3,100 2,900 0.017 03/31
Acrospire Investment Managemen 2,472 2,472 0.014 03/31
UBS Financial Services Inc. 2,000 2,000 0.011 03/31
Advocacy Wealth Management LLC 1,000 0 0.006 03/31
Morgan Stanley Smith Barney LL 700 0 0.004 03/31
NEXT Financial Group Inc. 500 500 0.003 06/30
WFG Advisors LP 400 0 0.002 03/31
Citigroup Global Markets Inc. 0 (7,500) 0.000 03/31
Recent MBRX News
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/13/2024 02:53:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 11:30:14 AM
- Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update • PR Newswire (US) • 05/13/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:30:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:30:13 PM
- Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin • PR Newswire (US) • 05/09/2024 12:30:00 PM
- Moleculin to Report First Quarter 2024 Financial Results on May 10, 2024 and Host Conference Call and Webcast • PR Newswire (US) • 05/08/2024 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 12:31:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:13:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 12:55:19 PM
- Moleculin Reports Higher AML Complete Remission (CR) Rates and Significant Durability with Additional Interim Subject Data • PR Newswire (US) • 05/07/2024 12:55:00 PM
- Moleculin to Host Virtual AML Clinical Day Featuring Internationally Renowned Clinician, Martin S. Tallman, MD, on May 7, 2024 • PR Newswire (US) • 05/02/2024 01:00:00 PM
- Moleculin Announces Formation of Scientific Advisory Board to Support Development of Annamycin • PR Newswire (US) • 05/01/2024 12:50:00 PM
- European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's Treatment of Acute Myeloid Leukemia (AML) • PR Newswire (US) • 04/18/2024 12:30:00 PM
- Moleculin Announces Presentation of Positive Data Demonstrating High Anti-Cancer Activity of Annamycin and Non-Cardiotoxic Properties • PR Newswire (US) • 04/10/2024 12:30:00 PM
- Moleculin to Present at the MedInvest Biotech & Pharma Investor Conference • PR Newswire (US) • 03/28/2024 02:45:00 PM
- Moleculin to Participate in the Virtual Investor Lunch Break: The Moleculin Opportunity • PR Newswire (US) • 03/27/2024 01:25:00 PM
- Moleculin Announces U.S. Patent Issue Notification for Annamycin Targeting Unmet Need in AML • PR Newswire (US) • 03/27/2024 01:05:00 PM
- Moleculin Announces Positive Interim Data in Annamycin MB-106 Phase 1B/2 AML Trial • PR Newswire (US) • 03/25/2024 11:30:00 AM
- Moleculin Reports Full Year 2023 Financial Results • PR Newswire (US) • 03/22/2024 08:05:00 PM
- Moleculin to Report Full Year 2023 Financial Results on March 22, 2024 and Host Conference Call and Webcast • PR Newswire (US) • 03/20/2024 11:30:00 AM
- JPMorgan boosts dividends, Chipotle unveils 50:1 stock split, and Latest News • IH Market News • 03/20/2024 11:15:48 AM
- Moleculin Announces Reverse Stock Split • PR Newswire (US) • 03/19/2024 08:30:00 PM
- Moleculin to Present at the 36th Annual ROTH Conference • PR Newswire (US) • 03/12/2024 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 01:30:16 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM